Mersana Therapeutics, Inc. Business Finance Contracts & Agreements
23 Contracts & Agreements
- Exchange Agreements (1 contract)
- Indenture Agreements (1)
- Investor Rights Agreements (1)
- Loan Agreements (9)
- Stock Agreements (6)
- Underwriting Agreements (3)
- Warrant Agreements (2)
- Form of Restricted Stock Unit Agreement for Employees under the (Filed With SEC on August 8, 2023)
- Form of Restricted Stock Unit Agreement under (Filed With SEC on August 8, 2023)
- Fourth Amendment to Loan and Security Agreement, dated March 23, 2023, between Oxford Finance LLC, the Lenders named therein including Silicon Valley Bridge Bank, N.A., and... (Filed With SEC on May 9, 2023)
- 2017 Employee Stock Purchase Plan (Filed With SEC on February 28, 2023)
- Third Amendment to Loan and Security Agreement, dated December 27, 2022, between Oxford Finance LLC, the Lenders named therein including Silicon Valley Bank, and Mersana... (Filed With SEC on February 28, 2023)
- Second Amendment to Loan and Security Agreement, dated October 17, 2022, between Oxford Finance LLC, the Lenders named therein including Silicon Valley Bank, and Mersana... (Filed With SEC on February 28, 2023)
- First Amendment to Loan and Security Agreement, dated February 17, 2022, between Oxford Finance LLC, the Lenders named therein including Silicon Valley Bank, and the Company (Filed With SEC on May 9, 2022)
- Form of Inducement Restricted Stock (Filed With SEC on February 28, 2022)
- Loan and Security Agreement, dated October 29, 2021, by and between Oxford Finance LLC, Silicon Valley Bank and Mersana Therapeutics, Inc (Filed With SEC on February 28, 2022)
- Second Amendment to Loan and Security Agreement, dated August 28, 2020, by and between Mersana Therapeutics, Inc, and Silicon Valley Bank (Filed With SEC on September 3, 2020)
- Underwriting Agreement, dated May 28, 2020, among Mersana Therapeutics, Inc. and Cowen and Company, LLC and SVB Leerink LLC, as representatives of the several underwriters listed... (Filed With SEC on June 1, 2020)
- Description of Registrants Common Stock (Filed With SEC on February 28, 2020)
- Exchange Agreement between Mersana Therapeutics, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, L.P., dated... (Filed With SEC on November 27, 2019)
- Form of Exchange Warrant (Filed With SEC on November 27, 2019)
- First Amendment to Loan and Security Agreement, dated June 21, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on August 8, 2019)
- Loan and Security Agreement dated May 8, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on August 8, 2019)
- Loan and Security Agreement dated May 8, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on May 9, 2019)
- Underwriting Agreement, dated February 28, 2019, by and among Mersana Therapeutics, Inc. and SVB Leerink LLC, as the representative of the several underwriters listed on Schedule... (Filed With SEC on March 4, 2019)
- MERSANA THERAPEUTICS, INC. 2017 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 16, 2017)
- MERSANA THERAPEUTICS, INC. [] Shares of Common Stock, par value $0.0001 per share Underwriting Agreement (Filed With SEC on June 16, 2017)
- INDENTURE OF LEASE by and between RIVERTECH ASSOCIATES II, LLC (LESSOR) and MERSANA THERAPEUTICS, INC. (LESSEE) (Filed With SEC on June 1, 2017)
- MERSANA THERAPEUTICS, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on June 1, 2017)
- WARRANT TO PURCHASE COMMON STOCK OF MERSANA THERAPEUTICS, INC. (A DELAWARE CORPORATION) SEPTEMBER 27, 2013 (Filed With SEC on June 1, 2017)